News & Articles

The new solutions support evolving industry needs such as COVID-19 response, disease models, and drug discovery

The collaboration aims to advance the scale-up of hMSC manufacturing for regenerative medicine

Watch this on-demand webinar to learn about an alternative assay that aims to identify virus-neutralizing antibodies in as little as five hours

Watch this on-demand webinar to find out how targeting B-cell maturation antigen and GPRC5D simultaneously could help to prevent tumor cell escape

Here’s what you should know when choosing the best bottles for your cell culture experiment

Researchers recommend that targeted nutrition should be urgently explored as a counter-measure to mitochondrial damage

All the talks and resources exploring the latest research and methods in the field are now available free and on demand - but for a limited time only

Internationally renowned Hans Clevers Lab reports using AMSBIO’s CELLBANKER reagent to freeze down their organoids ahead of the COVID-19 spring lockdown

Collaboration to develop next-generation CAR-T cell therapies with improved efficacy and durability

Addition of CRISPR and RNAi offerings to complement PerkinElmer's life sciences and applied genomics solutions, with future opportunities to improve cell based discovery for precision medicine

From Alzheimer’s disease to 3D brain modeling: Watch top speakers and connect with leading neuroscience innovators online, November 17-18

Which new products made the most difference to your lab work this year?

Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies

The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients

Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication

Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies

EpiMOGRIFY supports the development of scalable off-the-shelf cell therapies for diseases with a high unmet clinical need